ID: ALA3245417

Max Phase: Preclinical

Molecular Formula: C30H30N6O3

Molecular Weight: 522.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)c1ccc(OCc2cc(COc3ccc(C(=N)N)cc3)cc(COc3ccc(C(=N)N)cc3)c2)cc1

Standard InChI:  InChI=1S/C30H30N6O3/c31-28(32)22-1-7-25(8-2-22)37-16-19-13-20(17-38-26-9-3-23(4-10-26)29(33)34)15-21(14-19)18-39-27-11-5-24(6-12-27)30(35)36/h1-15H,16-18H2,(H3,31,32)(H3,33,34)(H3,35,36)

Standard InChI Key:  MEXFTCPLIHLBSF-UHFFFAOYSA-N

Associated Targets(Human)

Trypsin 2137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acrosin 53 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 522.61Molecular Weight (Monoisotopic): 522.2379AlogP: 4.28#Rotatable Bonds: 12
Polar Surface Area: 177.30Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 12.29CX LogP: 3.44CX LogD: -3.80
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.12Np Likeness Score: -0.12

References

1. Parrish RF, Straus JW, Paulson JD, Polakoski KL, Tidwell RR, Geratz JD, Stevens FM..  (1978)  Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives.,  21  (11): [PMID:722718] [10.1021/jm00209a008]

Source